Effectiveness of cognitive behavior treatment for pediatric obsessive-compulsive disorder: Acute outcomes from the Nordic Long-term OCD Treatment Study (NordLOTS)

Behaviour Research and Therapy

Volumn 64, Issue , 2015, Pages 15-23

  Torp, Nor Christian ^a,g   Dahl, Kitty ^a   Skarphedinsson, Gudmundur ^a   Thomsen, Per Hove ^b   Valderhaug, Robert ^c   Weidle, Bernhard ^c   Melin, Karin Holmgren ^d   Hybel, Katja ^b   Nissen, Judit Becker ^b   Lenhard, Fabian ^e   Wentzel Larsen, Tore ^a   Franklin, Martin E ^f   Ivarsson, Tord ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g Vestre Viken Hospital   (Norway)

Author keywords

Child and adolescent; Cognitive behavioral therapy; Exposure and response prevention; Obsessive compulsive disorder; Treatment outcome

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; CONTROLLED STUDY; DENMARK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CARE; MENTAL HEALTH CENTER; NORWAY; OBSESSIVE COMPULSIVE DISORDER; OUTCOME ASSESSMENT; SWEDEN; THERAPY EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; FAMILY THERAPY; LONGITUDINAL STUDY; OBSESSIVE-COMPULSIVE DISORDER; PROCEDURES; PSYCHOLOGY; TREATMENT OUTCOME;

ADOLESCENT; CHILD; COGNITIVE THERAPY; DENMARK; FAMILY THERAPY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; NORWAY; OBSESSIVE-COMPULSIVE DISORDER; SWEDEN; TREATMENT OUTCOME;

EID: 84913553902     PISSN: 00057967     EISSN: 1873622X     Source Type: Journal    
DOI: 10.1016/j.brat.2014.11.005     Document Type: Article

References (58)

1. AACAP Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2012, 51(1):98-113. 10.1016/j.jaac.2011.09.019.
2. Abramowitz J.S., Whiteside S.P., Deacon B.J. The effectiveness of treatment for pediatric obsessive-compulsive disorder: a meta-analysis. Behavior Therapy 2005, 36(1):55-63. 10.1016/S0005-7894%2805%2980054-1.
3. American Psychiatric Association DSM-IV-TR. Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC.
4. Barrett P.M., Healy-Farrell L., March J.S. Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry 2004, 43(1):46-62. 10.1097/00004583-200401000-00014.
5. Benazon N.R., Ager J., Rosenberg D.R. Cognitive behavior therapy in treatment-naive children and adolescents with obsessive-compulsive disorder: an open trial. Behaviour Research and Therapy 2002, 40(5):529-539.
6. Bloch M.H., Landeros-Weisenberger A., Rosario M.C., Pittenger C., Leckman J.F. Meta-analysis of the symptom structure of obsessive-compulsive disorder. The American Journal of Psychiatry 2008, 165(12):1532-1542. 10.1176/appi.ajp.2008.08020320.
7. Bolton D., Perrin S. Evaluation of exposure with response-prevention for obsessive compulsive disorder in childhood and adolescence. Journal of Behavior Therapy and Experimental Psychiatry 2008, 39(1):11-22. 10.1016/j.jbtep.2006.11.002.
8. Bolton D., Williams T., Perrin S., Atkinson L., Gallop C., Waite P., et al. Randomized controlled trial of full and brief cognitive-behaviour therapy and wait-list for paediatric obsessive-compulsive disorder. Journal of Child Psychology and Psychiatry 2011, 52(12):1269-1278. 10.1111/j.1469-7610.2011.02419.x.
9. Chambless D.L., Hollon S.D. Treatment validity for intervention studies. Research designs: Quantitative, qualitative, neuropsychological, and biological 2012, Vol. 2:529-552. American Psychological Association, Washington, DC. H. Cooper, P.M. Camic, D.L. Long, A.T. Panter, D. Rindskopf, K.J. Sher (Eds.).
10. Fitzmaurice G.M., Laird N.M., Ware J.H. Applied longitudinal analysis 2011, Wiley, Hoboken, NJ.
11. Franklin M.E., Kozak M.J., Cashman L.A., Coles M.E., Rheingold A.A., Foa E.B. Cognitive-behavioral treatment of pediatric obsessive-compulsive disorder: an open clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry 1998, 37(4):412-419.
12. Franklin M.E., Sapyta J., Freeman J.B., Khanna M., Compton S., Almirall D., et al. Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. JAMA 2011, 306(11):1224-1232. 10.1001/jama.2011.1344.
13. Freeman J., Sapyta J., Garcia A., Compton S., Khanna M., Flessner C., et al. Family-based treatment of early childhood obsessive-compulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study for young children (POTS Jr)-a randomized clinical trial. JAMA Psychiatry 2014, 71(6):689-698. 10.1001/jamapsychiatry.2014.170.
14. Gallant J., Storch E.A., Merlo L.J., Ricketts E.D., Geffken G.R., Goodman W.K., et al. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom checklist. Journal of Anxiety Disorders 2008, 22(8):1369-1376.
15. Geller D.A., Biederman J., Jones J., Shapiro S., Schwartz S., Park K.S. Obsessive-compulsive disorder in children and adolescents: a review. Harvard Review of Psychiatry 1998, 5(5):260-273.
16. Geller D.A., Biederman J., Stewart S.E., Mullin B., Farrell C., Wagner K.D., et al. Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?. Journal of Child and Adolescent Psychopharmacology 2003, 13(Suppl.1):S19-S29.
17. Geller D.A., Biederman J., Stewart S.E., Mullin B., Martin A., Spencer T., et al. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. American Journal of Psychiatry 2003, 160(11):1919-1928.
18. Geller D.A., Marsch J.S., Walter H.J., Bukstein O., Benson R.S., Chrisman A. Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2012, 51(1):98-113. 10.1016/j.jaac.2011.09.019.
19. Godwin M., Ruhland L., Casson I., MacDonald S., Delva D., Birtwhistle R., et al. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. BMC Medical Research Methodology 2003, 3:28.
20. Gueorguieva R., Krystal J.H. Move over ANOVA progress in analyzing repeated-measures data and its reflection in papers published in the archives of general psychiatry. Archives of General Psychiatry 2004, 61(3):310-317. 10.1001/archpsyc.61.3.310.
21. de Haan E., Hoogduin K.A., Buitelaar J.K., Keijsers G.P. Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 1998, 37(10):1022-1029.
22. Heyman I., Fombonne E., Simmons H., Ford T., Meltzer H., Goodman R. Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health. International Review of Psychiatry 2003, 15(1-2):178-184.
23. Ivarsson T., Thomsen P.H., Dahl K., Valderhaug R., Weidle B., Nissen J.B., et al. The rationale and some features of the Nordic Long-Term OCD Treatment Study (NordLOTS) in childhood and adolescence. Child & Youth Care Forum 2010, 39(2):91-99. 10.1007/s10566-010-9097-3.
24. Jacobson N.S., Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 1991, 59(1):12-19.
25. Kaufman J., Birmaher B., Brent D., Rao U. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry 1997, 36(7):980-988. 10.1097/00004583-199707000-00021.
26. Lauth B., Arnkelsson G.B., Magnusson P., Skarpheethinsson G.A., Ferrari P., Petursson H. Validity of K-SADS-PL (Schedule for Affective Disorders and Schizophrenia for School-Age children-Present and Lifetime Version) depression diagnoses in an adolescent clinical population. Nordic Journal of Psychiatry 2010, 64(6):409-420.
27. Leonard H.L., Swedo S.E., Lenane M.C., Rettew D.C., Hamburger S.D., Bartko J.J., et al. A2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents. Archives of General Psychiatry 1993, 50(6):429-439.
28. March J.S., Mulle K., Foa E., Kozak M.J. Treatment of pediatric obsessive-compulsive disorder cognitive behavior therapy treatment manual 2000.
29. March J.S., Mulle K., Herbel B. Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: an open trial of a new protocol-driven treatment package. Journal of the American Academy of Child and Adolescent Psychiatry 1994, 33(3):333-341. 10.1097/00004583-199403000-00006.
30. Morris S.B., DeShon R.P. Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychological Methods 2002, 7(1):105-125. 10.1037/1082-989x.7.1.105.
31. Nelson E., Rice J. Stability of diagnosis of obsessive-compulsive disorder in the epidemiologic catchment area study. American Journal of Psychiatry 1997, 154(6):826-831.
32. NICE Obsessive compulsive disorder (OCD) and body dysmorphic disorder (BDD) 2005, from. http://guidance.nice.org.uk/CG31.
33. Peris T.S., Bergman R., Langley A., Chang S., McCracken J.T., Piacentini J. Correlates of accommodation of pediatric obsessive-compulsive disorder: parent, child, and family characteristics. Journal of the American Academy of Child and Adolescent Psychiatry 2008, 47(10):1173-1181. 10.1097/CHI.0b013e3181825a91.
34. Piacentini J., Bergman R., Chang S., Langley A., Peris T.S., Wood J.J., et al. Controlled comparison of family cognitive behavioral therapy and psychoeducation/relaxation training for child obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2011, 50(11):1149-1161. 10.1016/j.jaac.2011.08.003.
35. Piacentini J., Bergman R., Keller M.B., McCracken J. Functional impairment in children and adolescents with obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology 2003, 13(Suppl.2):S61-S69. 10.1089/104454603322126359.
36. Piacentini J., Langley A., Roblek T. Cognitive behavioral treatment of childhood OCD: It's only a false alarm : Therapist guide 2007, Oxford University Press, New York, NY.
37. POTS Treatment Study Team Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 2004, 292(16):1969-1976.
38. R Development Core Team R: A language and enviroment for statistical computing 2008, from. http://www.R-project.org.
39. Reynolds S.A., Clark S., Smith H., Langdon P.E., Payne R., Bowers G., et al. Randomized controlled trial of parent-enhanced CBT compared with individual CBT for obsessive-compulsive disorder in young people. Journal of Consulting and Clinical Psychology Dec 2013, 81(6):1021-1026.
40. Riddle M. Obsessive-compulsive disorder in children and adolescents. British Journal of Psychiatry - Supplementum 1998, 35:91-96.
41. Scahill L., Riddle M.A., McSwiggin-Hardin M., Ort S.I. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry 1997, 36(6):844-852. 10.1097/00004583-199706000-00023.
42. Storch E.A., Bussing R., Small B.J., Geffken G.R., McNamara J.P., Rahman O., et al. Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder. Behaviour Research and Therapy 2013, 51(12):823-829. 10.1016/j.brat.2013.09.007.
43. Storch E.A., Geffken G.R., Merlo L.J., Jacob M.L., Murphy T.K., Goodman W.K., et al. Family accommodation in pediatric obsessive-compulsive disorder. Journal of Clinical Child and Adolescent Psychology 2007, 36(2):207-216.
44. Storch E.A., Lehmkuhl H.D., Ricketts E., Geffken G.R., Marien W., Murphy T.K. An open trial of intensive family based cognitive-behavioral therapy in youth with obsessive-compulsive disorder who are medication partial responders or nonresponders. Journal of Clinical Child & Adolescent Psychology 2010, 39(2):260-268. 10.1080/15374410903532676.
45. Storch E.A., Lewin A.B., De Nadai A.S., Murphy T.K. Defining treatment response and remission in obsessive-compulsive disorder: a signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale. Journal of the American Academy of Child and Adolescent Psychiatry 2010, 49(7):708-717. 10.1016/j.jaac.2010.04.005.
46. Storch E.A., Murphy T.K., Geffken G.R., Soto O., Sajid M., Allen P., et al. Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale. Psychiatry Research 2004, 129(1):91-98. 10.1016/j.psychres.2004.06.009.
47. Taylor S., Asmundson G.J., Jang K.L. Etiology of obsessive-compulsive symptoms and obsessive-compulsive personality traits: common genes, mostly different environments. Depression and Anxiety 2011, 28(10):863-869. 10.1002/da.20859.
48. Thomsen P.H. Obsessions: the impact and treatment of obsessive-compulsive disorder in children and adolescents. Journal of Psychopharmacology 2000, 14(2 Suppl.1):S31-S37.
49. Thomsen P.H., Torp N.C., Dahl K., Christensen K., Englyst I., Melin K.H., et al. The Nordic long-term OCD treatment study (NordLOTS): rationale, design, and methods. Child and Adolescent Psychiatry and Mental Health 2013, 7(1):41. 10.1186/1753-2000-7-41.
50. Tolin D.F., Abramowitz J.S., Diefenbach G.J. Defining response in clinical trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale. Journal of Clinical Psychiatry 2005, 66(12):1549-1557.
51. Twisk J., de Vente W. Attrition in longitudinal studies. How to deal with missing data. Journal of Clinical Epidemiology 2002, 55(4):329-337.
52. Valderhaug R., Ivarsson T. Functional impairment in clinical samples of Norwegian and Swedish children and adolescents with obsessive-compulsive disorder. European Child and Adolescent Psychiatry 2005, 14(3):164-173. 10.1007/s00787-005-0456-9.
53. Valderhaug R., Larsson B., Gotestam K.G., Piacentini J. An open clinical trial of cognitive-behaviour therapy in children and adolescents with obsessive-compulsive disorder administered in regular outpatient clinics. Behaviour Research and Therapy 2007, 45(3):577-589. 10.1016/j.brat.2006.04.011.
54. Watson H.J., Rees C.S. Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder. Journal of Child Psychology and Psychiatry and Allied Disciplines 2008, 49(5):489-498. 10.1111/j.1469-7610.2007.01875.x.
55. Weisz J.R., Weiss B., Donenberg G.R. The lab versus the clinic: effects of child and adolescent psychotherapy. Annual Progress in Child Psychiatry & Child Development 1993, 441-458.
56. Wever C., Rey J.M. Juvenile obsessive-compulsive disorder. Australian and New Zealand Journal of Psychiatry 1997, 31(1):105-113.
57. Williams M., Powers M., Yun Y.-G., Foa E. Minority participation in randomized controlled trials for obsessive-compulsive disorder. Journal of Anxiety Disorders 2010, 24(2):171-177. 10.1016/j.janxdis.2009.11.004.
58. Ziegler A., Vens M. Generalized estimating equations. Notes on the choice of the working correlation matrix. Methods of Information in Medicine 2010, 49(5):421-432. 10.3414/ME10-01-0026.